Practice Area Focus
- Combination Products
- Orphan Drugs
- Clinical Development Strategy
- Clinical Study Design
- Health Technology Assessment
Dr. Steven Brooks joined NDA Partners as an Expert Consultant in 2016. Dr. Brooks was formerly a Medical Officer, Peripheral Vascular Device Branch, Office of Device Evaluation at FDA, where he was a key member of the FDA Medical Devices Reimbursement Task Force and a member of the FDA Entrepreneur-in-Residence Program to streamline the approval-to-reimbursement pathway for devices.
In addition to his FDA experience, Dr. Brooks was Vice President of Regulatory Affairs and Health Economics for Ablative Solutions (ASI); Medical Device Executive for the TEDCO mdPACE Program, TEDCO Life Science Investment Fund Reviewer, and Maryland Innovation Initiative (MII) Reviewer for the Maryland Technology Development Corporation (TEDCO). Dr. Brooks also served as Chief Innovation Officer for Sage Growth Partners and is an active Senior Advisor for Popper and Company, a healthcare consulting firm focusing on healthcare technology.
Dr. Brooks is an expert Interventional Cardiologist, formerly as a faculty member at the University of Maryland Medical Center and then in private practice. He serves on several Advisory Boards for Glysend, Renalert, and Mammoth Health Innovation.